This program focuses on molecular imaging methods to guide individualized, precision medicine treatment for breast cancer patients with the goal of more effective, less toxic treatment.
Research also seeks to elucidate the in vivo biology of breast cancer, using imaging. Current research focuses mostly on PET-based method to imaging cancer metabolism, proliferation and quiescence, tumor receptor expression and response to targeted therapy. The program brings together faculty specialists and key staff with experience in molecular imaging, breast imaging, oncology, breast surgery, clinical imaging study design and data analysis.
In addition to NIH and DOE funding, the program is supported by a grant from the Susan G. Komen Foundation, which supports Dr. Mankoff’s work as a Komen Scholar.